D. Rosik

Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules.

J. Feldwisch, V. Tolmachev, A. Orlova, 2008, Bioconjugate chemistry.

Direct comparison of 111In-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging

A. Karlström, V. Tolmachev, A. Orlova, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging

L. Abrahmsén, V. Tolmachev, A. Orlova, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Incorporation of a triglutamyl spacer improves the biodistribution of synthetic affibody molecules radiofluorinated at the N-terminus via oxime formation with (18)F-4-fluorobenzaldehyde.

G. Antoni, V. Tolmachev, A. Orlova, 2014, Bioconjugate chemistry.

Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA.

V. Tolmachev, A. Orlova, Mohamed Altai, 2013, Bioconjugate chemistry.

Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors.

H. Lundqvist, V. Tolmachev, M. Sandström, 2007, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Design of an optimized scaffold for affibody molecules.

Joachim Feldwisch, Vladimir Tolmachev, Anna Sjöberg, 2010, Journal of molecular biology.

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.

Vladimir Tolmachev, Hans Lundqvist, Mattias Sandström, 2007, Cancer research.

Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry

S. Ståhl, V. Tolmachev, F. Frejd, 2009, Journal of Nuclear Medicine.

Site-specific radiometal labeling and improved biodistribution using ABY-027 , a novel HER 2-targeting affibody molecule-ABD fusion protein

H. Lundqvist, C. Ekblad, A. Jonsson, 2014 .

Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule–Albumin-Binding Domain Fusion Protein

Fredrik Y Frejd, H. Lundqvist, L. Abrahmsén, 2013, The Journal of Nuclear Medicine.

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

Vladimir Tolmachev, Karl Andersson, Lars Gedda, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition

L. Abrahmsén, V. Tolmachev, A. Orlova, 2012, The Journal of Nuclear Medicine.

Evaluation of backbone-cyclized HER2-binding 2-helix affibody molecule for in vivo molecular imaging.

Nima Jokilaakso, A. Karlström, V. Tolmachev, 2013, Nuclear medicine and biology.

Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with 18F-Labeled Affibody Molecule ZHER2:2395 in a Mouse Model for Ovarian Cancer

Vladimir Tolmachev, Peter Laverman, W. Oyen, 2012, The Journal of Nuclear Medicine.

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount

Vladimir Tolmachev, Mattias Sandström, Anna Sjöberg, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Photo-controlled reversible binding between the protein A-derived Z domain and immunoglobulin G.

A. Karlström, D. Rosik, Anders Myrhammar, 2020, Bioconjugate chemistry.

On the Design of Affibody Molecules for Radiolabeling and In Vivo Molecular Imaging

D. Rosik, 2013 .

Evaluation of backbone-cyclized HER2-binding 2-helix affibody molecule for in vivo molecular imaging.

Nima Jokilaakso, A. Karlström, V. Tolmachev, 2013, Nuclear medicine and biology.